Recombinant Hepatitis B vaccine (Saccharomyces cerevisiae
Product Description
Beijing Minhai Biotechnology Co., Ltd
-
CN
-
2023On CPHI since
-
1Certificates
-
1000 - 4999Employees
Company types
Primary activities
Categories
Specifications
Beijing Minhai Biotechnology Co., Ltd
-
CN
-
2023On CPHI since
-
1Certificates
-
1000 - 4999Employees
Company types
Primary activities
More Products from Beijing Minhai Biotechnology Co., Ltd (2)
-
Product 13-valent pneumococcal conjugate vaccine
Protects against infectious diseases caused by pneumococcal types 1,3,4,5,6A,6B,7F,9V,14,18C,19A,19F and 23F, including pneumonia, meningitis, otitis media, bacteremia.
-
Product Varicella Vaccine, Live
It can stimulate the body to produce immunity against varicella-zoster virus, which is used to prevent varicella.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance